BioStem Technologies (OTC: BSEM) logo

BioStem Technologies (OTC: BSEM)

We Manufacture Products That Change Lives

47 employees · est. 2014 · Pompano Beach, United States

VS
Lonza Netherlands, former PharmaCell logo

Lonza Netherlands, former PharmaCell

192 employees · est. 2005 · Maastricht, The Netherlands

Lonza Netherlands, former PharmaCell is the older company (2014 vs 2005); Lonza Netherlands, former PharmaCell is the larger of the two.

Side-by-Side Comparison

BioStem Technologies (OTC: BSEM) Lonza Netherlands, former PharmaCell
Founded
2014 2005 older
Headquarters
Pompano Beach, United States Maastricht, The Netherlands
Employees
47 192 larger
Industry
Biotechnology, Pharmaceutical Fashion, Manufacturing
Funding Stage
Post Ipo Equity Series Unknown
Total Funding
$2.00M $2.00M
Funding Rounds
1 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Regenerative Medicine, Perinatal Tissue, Allografts, BioRetain Processing, Growth Factors Preservation, Quality Management, AATB Accreditation, CGTP, CGMP, FDA Registered, VENDAJE, Placental Allograft Not tracked yet
Website
biostemtechnologies.com pharmacell.nl
BioStem Technologies (OTC: BSEM) logo

About BioStem Technologies (OTC: BSEM)

BioStem Technologies (OTC: BSEM) is a leading innovator in the biotechnology and pharmaceutical industries, specializing in the development, manufacture, and commercialization of allografts for regenerative therapies. The company's BioRetain processing method is at the core of its focus on manufactu...

Lonza Netherlands, former PharmaCell logo

About Lonza Netherlands, former PharmaCell

Lonza Netherlands, former PharmaCell Lonza Netherlands is a Contract Manufacturing Organization (CMO) in the area of cell therapy and regenerative medicine (tissue culturing). Founded in 2005, the company operates two state-of-the-art cGMP-licensed facilities for human cell & tissue culturing in Maa...

We will tell you when either one moves

BounceWatch watches BioStem Technologies (OTC: BSEM) and Lonza Netherlands, former PharmaCell for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at BioStem Technologies (... and Lonza Netherlands, for... — by email.

Frequently Asked Questions

BioStem Technologies (OTC: BSEM) — We Manufacture Products That Change Lives. Lonza Netherlands, former PharmaCell. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
BioStem Technologies (OTC: BSEM) has raised $2.00M while Lonza Netherlands, former PharmaCell has raised $2.00M.
BioStem Technologies (OTC: BSEM) and Lonza Netherlands, former PharmaCell operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare BioStem Technologies (OTC: BSEM) with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at BioStem Technologies (OTC: BSEM) on 12 Sep 2024, and Lonza Netherlands, former PharmaCell on 14 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy